Covid-19 impact: Low-interest loans likely for vaccine companies

Low-cost funding arrangements are already in the works globally for vaccine makers

As Indian vaccine candidates inch closer towards Phase 3 trials in December, talks on the government likely to facilitate low interest loans to these players to help scale up production are gaining ground. 

Multiple sources within the vaccine industry in India said while there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made available to these players only when the time to scale up manufacturing arises. 

“It seems like the government is waiting to see which candidate emerges successful before